Results 251 to 260 of about 130,240 (311)

Recombinant Yeast-Based Vaccines: Importance and Applications. [PDF]

Infect Dis Rep
Kumar R.
europepmc   +1 more source

Update on Hepatitis E Virus Infection 2025: Insights From an International Symposium

Liver International, Volume 45, Issue 11, November 2025.
ABSTRACT Background and Aims The second Hepatitis E Symposium was held as an integral part of the International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart in Berlin. The symposium aimed to provide a comprehensive exploration of hepatitis E virus (HEV) research and bring together clinicians, basic scientists, public health ...
Lara Buchardt, Viet Loan Dao Thi, Reimar Johne, Mathias Ziersch, Dominik Harms, Jörg Hofmann, Katja Dinkelborg, Mara Klöhn, Mira Choi, Jens Kurreck, Heiner Wedemeyer, Daniel Todt   +11 more
wiley   +1 more source

Hepatitis E Vaccination Preferences and Willingness-to-Pay Among Residents: A Discrete Choice Experiment Analysis. [PDF]

Vaccines (Basel)
Chen Y, Zhang C, Zou Z, Hu W, Zhang D, Zhao S, Zhang S, Wu Q, Zhang L.   +8 more
europepmc   +1 more source

Significant Decline in HCV‐Related Mortality From Liver Cirrhosis and Chronic Liver Disease (2015–2022): A Sentinel Center Study

Liver International, Volume 45, Issue 11, November 2025.
ABSTRACT Background Reducing mortality attributable to hepatitis C virus (HCV) is a key target in the World Health Organization (WHO) HCV elimination strategy. While liver cancer registration in Taiwan includes hepatitis C antibody (anti‐HCV) status, no national registry records viral etiologies for deaths from liver cirrhosis and chronic liver disease
Cheng‐Yeh Yang, Chih‐Yun Lin, Jing‐Houng Wang, Chun‐Yen Lin, Rong‐Nan Chien, Sheng‐Nan Lu   +5 more
wiley   +1 more source

Overview of vaccines for adults authorized, recommended, and implemented in the European Union. [PDF]

NPJ Vaccines
Pattyn J, Launay O, Steffen R, Weinberger B, Gabutti G, Ihan A, Weinke T, Jancoriene L, Bonanni P, Van Damme P.   +9 more
europepmc   +1 more source

Small Molecule Targeting of Atypical p38 Protects Against Viral Infection

The FASEB Journal, Volume 39, Issue 20, 31 October 2025.
Targeting host signaling pathways offers a complementary strategy to direct‐acting antivirals. Small‐molecule modulators of atypical p38 block Hepatitis C virus replication and also inhibit Human Cytomegalovirus. By disrupting virus‐induced p38 activation, these compounds suppress viral RNA replication and protein expression, highlighting atypical p38 ...
Fredejah T. Royer, Jeremy C. Burton, Johnathan Burns, Megan G. Lloyd, Reuben Onwe, Jennifer F. Moffat, Neil J. Grimsey   +6 more
wiley   +1 more source

Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations

Medical Journal of Australia, Volume 223, Issue 8, Page 426-436, October 2025.
Abstract Introduction Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, the sixth most common cause of cancer death in Australia. With shifting aetiologies and a growing at‐risk population, consistent routine surveillance recommendations are key to early detection of HCC and improved survival.
Jacob George, Nicole L Allard, Stuart K Roberts, Leon A Adams, Jane Davies, Behzad Hajarizadeh, Jennifer H MacLachlan, Suzanne E Mahady, Rosalie Altus, Catherine Brown, David C Fry, Belinda Greenwood‐Smith, Natali Smud, Patricia C Valery, Nafisa Yussf, Kate Broun, Denise Campbell, Karen Canfell, Chelsea Carle Harrison, Victoria Freeman, Paul Grogan, Catherine Holliday, Suzanne Hughes, Anna Kelly, Cathelijne van Kemenade, Claire Latumahina, Amanda McAtamney, Megan Varlow, Joachim Worthington, Susan Yuill, Eleonora Feletto   +30 more
wiley   +1 more source

Safety and Immunogenicity of Vaccines in Children with Kaposiform Hemangioendothelioma Receiving Sirolimus: A Prospective Study. [PDF]

Vaccines (Basel)
Yuan J, Yuan Z, Ding Y, Wang Z, Yao W, Li J, Zeng M, Li K.   +7 more
europepmc   +1 more source

Early IL‐1 Inhibition in Still's Disease: A Window of Opportunity for Improving Outcomes

ACR Open Rheumatology, Volume 7, Issue 10, October 2025.
Objective Still's disease is a complex, multisystemic disorder requiring prompt diagnosis and treatment. This study provides a general assessment of a Still's disease cohort aiming to evaluate the efficacy of early intervention with interleukin‐1 inhibitors (IL‐1i) in achieving clinical inactive disease (CID) and reducing glucocorticoid use in patients
Sara Bindoli, Cristina Cadore, Irina Guidea, Andrea Doria, Roberta Ramonda, Paolo Sfriso   +5 more
wiley   +1 more source

Hepatitis B vaccine knowledge, uptake and associated factors among healthcare workers in public secondary facilities in Delta Central District, Nigeria. [PDF]

Ghana Med J
Sajini OK, Ntaji MI, Awunor NS, Okumagba MT, Sajini OP.   +4 more
europepmc   +1 more source